Objectives

After participating in this educational activity, attendees should be able to:
1. Describe the pathophysiology of opioid use disorder.
2. Understand the recommended treatment of opioid use disorder in pregnancy.
3. Describe methods of harm reduction and their importance in the treatment of opioid use disorder.

Faculty

Megan R. Miller, MD, FACOG
Department of Obstetrics & Gynecology
Generalist Division
Baystate Medical Center
University of Massachusetts School of Medicine-Baystate

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                             

Session date: 
Thursday, February 20, 2020 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.